The prognostic value of serum levels of a proliferation-inducing ligand (APRIL) in treatment-naive patients with chronic lymphocytic leukemia
Date
2021Author
ONGOREN, Seniz
Esatoglu, Sinem Nihal
Keskin, Dilek
AR, Muhlis Cem
SALİHOĞLU, Ayşe
ELVERDİ, Tuğrul
EŞKAZAN, Ahmet Emre
Soysal, Teoman
UZUN, Hafize
Aydin, Yildiz
BAŞLAR, Zafer
Metadata
Show full item recordAbstract
Background/aim: A proliferation-inducing ligand (APRIL) has been investigated as a prognostic marker in chronic lymphocytic leukemia (CLL) patients. However, there is no cut-off level for serum APRIL (sAPRIL) levels that predict time to treatment in CLL patients.
Collections
- Makale [92796]